U46

(5E)-7-{6-[(1E)-3-HYDROXYOCT-1-ENYL]-2-OXABICYCLO[2.2.1]HEPT-5-YL}HEPT-5-ENOIC ACID

Created:	2005-11-11
Last modified:	2020-06-05

Find Related PDB Entry
1 entries where U46 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	59
Chiral Atom Count	5
Bond Count	60
Aromatic Bond Count	0

2D diagram of U46

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(5E)-7-{6-[(1E)-3-HYDROXYOCT-1-ENYL]-2-OXABICYCLO[2.2.1]HEPT-5-YL}HEPT-5-ENOIC ACID
Synonyms	9,11-DIDEOXY-9,11-METHANOEPOXY PROSTAGLANDIN F2
Systematic Name (OpenEye OEToolkits)	(Z)-7-[(1S,4R,5R,6S)-5-[(E,3R)-3-hydroxyoct-1-enyl]-3-oxabicyclo[2.2.1]heptan-6-yl]hept-5-enoic acid
Formula	C₂₁ H₃₄ O₄
Molecular Weight	350.492
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=C(O)CCC\C=C/CC2C(/C=C/C(O)CCCCC)C1OCC2C1
SMILES	CACTVS	3.341	CCCCC[CH](O)C=C[CH]1[CH]2C[CH](CO2)[CH]1CC=CCCCC(O)=O
SMILES	OpenEye OEToolkits	1.5.0	CCCCCC(C=CC1C2CC(C1CC=CCCCC(=O)O)CO2)O
Canonical SMILES	CACTVS	3.341	CCCCC[C@@H](O)/C=C/[C@H]1[C@H]2C[C@H](CO2)[C@@H]1C\C=C/CCCC(O)=O
Canonical SMILES	OpenEye OEToolkits	1.5.0	CCCCC[C@H](\C=C\[C@H]1[C@H]2C[C@@H]([C@@H]1C\C=C/CCCC(=O)O)CO2)O
InChI	InChI	1.03	InChI=1S/C21H34O4/c1-2-3-6-9-17(22)12-13-19-18(16-14-20(19)25-15-16)10-7-4-5-8-11-21(23)24/h4,7,12-13,16-20,22H,2-3,5-6,8-11,14-15H2,1H3,(H,23,24)/b7-4-,13-12+/t16-,17-,18+,19-,20-/m1/s1
InChIKey	InChI	1.03	LQANGKSBLPMBTJ-ZESXDWFFSA-N

Related Resource References

Resource Name	Reference
PubChem	52193880

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.